Mesynthes Obtains FDA 510(k) for Endoform Dermal Template

Mesynthes, a privately held regenerative medicine company, Tuesday announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Endoform Dermal Template.
GEN